BF
PCRX icon

BOK Financial’s Pacira BioSciences PCRX Stock Holding History

BOK Financial’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,844
Closed -$514K – 1093
2025
Q4 		$514K Sell
19,844
-105
-0.5% -$2.5K 0.01% 540
2025
Q3 		$514K Sell
19,949
-27
-0.1% -$663 0.01% 569
2025
Q2 		$477K Sell
19,976
-101
-0.5% -$2.55K 0.01% 577
2025
Q1 		$499K Sell
20,077
-7,135
-26% -$171K 0.01% 559
2024
Q4 		$562K Buy
+27,212
New +$478K 0.01% 530

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BOK Financial's PCRX Position: Q1 2026 in Review

BOK Financial sold out of Pacira BioSciences (PCRX) in Q1 2026, closing a stake of 19,844 shares — an estimated $514K sold.

BOK Financial first reported a position in PCRX in Q4 2024 and held it in 5 quarters. The position peaked at $562K in Q4 2024. 242 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • BOK Financial reported no remaining Pacira BioSciences position as of Q1 2026 after selling out during the quarter.
  • BOK Financial sold 19,844 Pacira BioSciences shares in Q1 2026, an estimated $514K.
  • BOK Financial first reported a position in Pacira BioSciences in Q4 2024 and held it in 5 quarters.
  • BOK Financial's Pacira BioSciences position peaked at $562K in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on BOK Financial's 13F filing for Q1 2026, filed 8 May 2026.